comprehensive -WSS

comprehensive

author：fashion 2025-09-02 13:53:50 - browse：23373

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： New Medicare drug pricing powers could soon be upended in court

WSS

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

Biotech reporter’s notebook: A sunnier mood at JPM 2024

GOP inquiry over gain

Eating disorder hotline's move to chatbot carried cost for volunteers

Fauci’s Covid grilling leads GOP to weigh foreign research rules

JPM 2024: Verve Therapeutics looks to mainstream genome editing

hotspot

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth wins $3.3 billion takeover of Amedisys

How to save PrEP access — and even expand it

HHS names first

Virginia high school admissions case could be legal follow

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Medical leaders decry Supreme Court decision on affirmative action

How I ended up pumping milk in a bathroom stall at JPM 2024

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

hotspot

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

Ukrainian soldiers say they owe lives to US

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

JPM 2024: Verve Therapeutics looks to mainstream genome editing

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

hotspot

explore

hotspot

hotspot